Rice professor evolves new Cas9 enzymes image: Sequence Display-enabled deep learning helps improve SlugCas9, a compact CRISPR tool, to edit challenging DNA sites in APOC3 and PCSK9, two genes linked to coronary heart disease risk. view more Credit: Rice University/Linqi Cheng and Han…
Published 5 November 2026, 9:55 Scientists have developed three-dimensional, lens-like structures from human stem cells in a laboratory, offering researchers a new way to investigate how the eye develops and how conditions such as cataracts affect vision. The research, published on October 15, 2026, in…
Meeting the shift to precision editing IDT has also released Alt-R CRISPR-Cas9 sgRNA XT to maximize editing performance across both base editing and Cas9-mediated workflows using mRNA. Together with the new IDT bioinformatics tool for pegRNA design, these solutions give…
A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial. The study was published…
“My hope is that one day Origin Genomics can help couples and families with these hereditary diseases not pass them down to their children, and still have as many healthy children as they’d like,” Tie said, according to the Origin…
Anthropic's biology research team and Claude mapped the first 3D structure of a bacterial vault particle from phage L05, resolving a 40-year biology mystery in an expanded 96-subunit cryo-EM model. We’re sharing how our biology research team worked with Claude to map…
Scientists have grown a realistic human lens from stem cells for the first time which could potentially pave the way for new treatments for cataracts and other eye conditions. In a new breakthrough, researchers from the UK's Anglia Ruskin University…
CHARLOTTESVILLE, Va. (WVIR) - Anonymous donors have given $6 million to the Manning Institute of Biotechnology at the University of Virginia. Mark Esser, inaugural chief scientific officer and head of the Manning Institute of Biotechnology, said the donation will support the SPARK…
By Jesse McCool, PhD For decades, biologics development has followed a familiar sequence: create an expression construct, transfect host cells, isolate single cells, screen hundreds or thousands of clones, select a lead clone, establish a cell bank, develop the process,…
4 hours ago 0 This effort does not change any requirements of patent law. The core matter considering the initiative is the following: when a medication against a rare disease has been tested in patients with certain genetic mutations, is there any…
CRISPR edits, delivery vectors, rare‑disease trials, and approvals.
An article joins this feed when it matches these terms. Each one is also a search of its own.